Jefferies Downgrades Rating On Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company

Do You Own Bristol-Myers Squibb Company (NYSE:BMY) Shares?

The price target set for the Bristol-Myers Squibb Company (BMY) is $59.55 and this sets up an interesting set of potential movement for the stock. Ameriprise Financial Inc. now owns 15,547,051 shares of the biopharmaceutical company's stock valued at $845,504,000 after buying an additional 2,451,390 shares in the last quarter.

Bristol-Myers Squibb Company has a consensus outperform rating from 23 Wall Street analysts, and the number of shares now sold short amount to at least 0.71% of shares outstanding. The stock exchanged hands with2088259 numbers of shares contrast to its average daily volume of 0.67 shares. The company's 3-months average volume stands at 6.05 million.

Bristol-Myers Squibb Company (NYSE:BMY) touched its 1-Year High price of $66.10 on 10/13/17 and its 1-Year Low price of $46.01 on 01/26/17. It has underperformed by 39.89% the S&P500.

M&T Bank Corp increased its stake in Analog Devices Inc (ADI) by 3.79% based on its latest 2017Q2 regulatory filing with the SEC. Its down 0.09, from 1.08 in 2017Q1. They are also projecting the Low EPS estimate of $0.59 and the High EPS estimate of $0.69. Moreover, Sir Capital Management L.P. has 4.47% invested in the company for 570,770 shares. The New York-based Broadfin Capital Llc has invested 0.05% in the stock. About 45 shares traded. It has outperformed by 9.72% the S&P500.

Among 30 analysts covering Southwestern Energy Company (NYSE:SWN), 10 have Buy rating, 3 Sell and 17 Hold. Therefore 100% are positive. Southwestern Energy Company had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Monday, June 12 by Jefferies. The rating was maintained by Leerink Swann on Thursday, July 27 with "Buy". On Wednesday, July 27 the stock rating was upgraded by Evercore to "Buy". The firm earned "Hold" rating on Monday, August 14 by Cowen & Co. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. RBC Capital Markets maintained Analog Devices, Inc. The rating was initiated by Hilliard Lyons with "Neutral" on Monday, May 23. As per Friday, July 1, the company rating was maintained by RBC Capital Markets.

More news for Analog Devices, Inc. The ex-dividend date of this dividend is Thursday, October 5th. The rating was maintained by Needham on Monday, August 3 with "Strong Buy". Real Peter had sold 3,000 shares worth $244,620 on Monday, May 22. TILDEN BRADLEY D sold $576,696 worth of stock or 6,500 shares.

Investors sentiment decreased to 1.14 in Q2 2017. Peak6 Investments Limited Partnership owns 17,953 shares. Its down 0.03, from 0.98 in 2017Q1. Company insiders own 0.23% of the company's stock. South Dakota Investment Council has invested 0% of its portfolio in Southwestern Energy Company (NYSE:SWN). Hutchin Hill Lp holds 0.18% or 135,400 shares. (NASDAQ:ADI) or 18,001 shares.

The EPS of Immunomedics, strolling at -1.44. After having $-0.72 EPS previously, Collegium Pharmaceutical Inc's analysts see 2.78% EPS growth. (NASDAQ:ADI) for 285,083 shares. Jennison Ltd Limited Liability Company reported 23.12 million shares. Fny Managed Accounts Ltd invested 0.12% of its portfolio in Southwestern Energy Company (NYSE:SWN). Conning Inc has invested 0.03% of its portfolio in Analog Devices, Inc. Renaissance Technologies LLC now owns 13,488,200 shares of the biopharmaceutical company's stock valued at $751,563,000 after buying an additional 7,020,200 shares in the last quarter. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the company. Therefore 26% are positive. On Wednesday, August 16 the stock rating was maintained by Credit Suisse with "Hold". The rating was initiated by Robert W. Baird with "Outperform" on Wednesday, April 26. The stock has "Hold" rating by Deutsche Bank on Friday, October 28. The stock has seen its SMA50 which is now 24.86%. The firm has "Hold" rating by Cowen & Co given on Friday, October 13. Finally, UBS AG reaffirmed a "buy" rating and set a $72.00 target price (up previously from $62.00) on shares of Bristol-Myers Squibb in a report on Friday, October 6th. The company was maintained on Tuesday, December 1 by Barclays Capital. The firm has "Buy" rating by Bank of America given on Tuesday, January 10.

Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.03, from 0.98 in 2017Q1. It improved, as 51 investors sold Alaska Air Group, Inc. shares while 150 reduced holdings.

A number of institutional investors and hedge funds have recently made changes to their positions in BMY. 8,230 were reported by Bingham Osborn And Scarborough Lc.

Shares of Bristol-Myers Squibb Company (NYSE:BMY) opened at 63.65 on Tuesday. Hall Laurie J Trustee owns 922 shares. Finally, V Wealth Management LLC purchased a new stake in shares of Bristol-Myers Squibb during the second quarter worth $126,000. The dividend will be $0.390 per share for the quarter which is $1.56 annualized. Broderick Brian C reported 25,740 shares. The legal version of this piece of content can be viewed at

Latest News